ISM3091

Exelixis, Insilico Medicine, LIB Therapeutics, licensing deal, artificial intelligence, ISM3091

Exelixis partners with AI company Insilico to discover new drugs, LIB sells China rights for PCSK9 drug

Anika Sharma

Exelixis, the pharmaceutical company recognized for its solid tumor medication Cabometyx, is adopting artificial intelligence (AI) to bolster its pipeline. ...